These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6510418)

  • 1. An improved synthesis of crystalline mammalian glucagon.
    Mojsov S; Merrifield RB
    Eur J Biochem; 1984 Dec; 145(3):601-5. PubMed ID: 6510418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-evaluation of glucagon1-6: the N-terminal hexapeptide of glucagon is not biologically active in the hepatic adenylate cyclase system.
    Pelton JT; Trivedi D; Hruby VJ
    Life Sci; 1983 Sep; 33(13):1307-14. PubMed ID: 6888179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid-phase synthesis of crystalline glucagon.
    Mojsov S; Merrifield RB
    Biochemistry; 1981 May; 20(10):2950-6. PubMed ID: 7248261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activity of glucagon-stimulated adenylate cyclase from rat liver plasma membranes is modulated by the fluidity of its lipid environment.
    Dipple I; Houslay MD
    Biochem J; 1978 Jul; 174(1):179-90. PubMed ID: 697751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of seven synthetic glucagon analogs, modified in position 1, 2 and/or 12, on liver and heart adenylate cyclase from rat.
    Robberecht P; Waelbroeck M; Camus JC; De Neef P; Coy DH; Christophe J
    Peptides; 1986; 7 Suppl 1():109-12. PubMed ID: 3018688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of the 10-13 region of glucagon for its receptor interactions and activation of adenylate cyclase.
    Krstenansky JL; Trivedi D; Hruby VJ
    Biochemistry; 1986 Jul; 25(13):3833-9. PubMed ID: 3017406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and hormonal activity of [Tyr22] glucagon and [desHis1, Tyr22] glucagon.
    Lu GS; Mojsov S; Merrifield RB
    Int J Pept Protein Res; 1987 Apr; 29(4):545-57. PubMed ID: 3454664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of specific trinitrophenylation of the lysine epsilon amino group of glucagon on receptor binding and adenylate cyclase activation.
    Liepnieks JJ; Epand RM
    Arch Biochem Biophys; 1983 Aug; 225(1):102-9. PubMed ID: 6311099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon antagonists. Synthesis and inhibitory properties of Asp3-containing glucagon analogs.
    Andreu D; Merrifield RB
    Eur J Biochem; 1987 May; 164(3):585-90. PubMed ID: 3032623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of glucagon partial agonists and antagonists.
    Gysin B; Trivedi D; Johnson DG; Hruby VJ
    Biochemistry; 1986 Dec; 25(25):8278-84. PubMed ID: 3814583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N alpha-Malto-glucagon and N alpha-malto, S-methyl methionine27-glucagon: preparation and characterization of two partial agonists.
    Coolican SA; Gurd RS
    Arch Biochem Biophys; 1984 Aug; 232(2):450-7. PubMed ID: 6380408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic peptide antagonists of glucagon.
    Unson CG; Andreu D; Gurzenda EM; Merrifield RB
    Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4083-7. PubMed ID: 3035568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylglucagon: preparation and characterization.
    Desbuguois B
    Eur J Biochem; 1975 Dec; 60(2):335-47. PubMed ID: 1270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of amidinated glucagons.
    Wright DE; Rodbell M
    Eur J Biochem; 1980 Oct; 111(1):11-6. PubMed ID: 7439177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semisynthetic derivatives of glucagon: (des-His1)N epsilon-acetimidoglucagon and N alpha-Biotinyl-N epsilon-acetimidoglucagon.
    Flanders KC; Mar DH; Folz RJ; England RD; Coolican SA; Harris DE; Floyd AD; Gurd RS
    Biochemistry; 1982 Aug; 21(18):4244-51. PubMed ID: 7126542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solubilization of glucagon and epinephrine sensitive adenylate cyclase from rat liver plasma membranes.
    Ryan J; Storm DR
    Biochem Biophys Res Commun; 1974 Sep; 60(1):304-11. PubMed ID: 4418132
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential acid stabilities of citraconylated amino groups of glucagon. Preparation of N alpha-citraconyl glucagon and evaluation of its biological properties.
    Liepnieks JJ; Epand RM
    Biochim Biophys Acta; 1982 Oct; 707(2):171-7. PubMed ID: 6291617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation of glucagon, characterization of the sulfonium derivative, and regeneration of the native covalent structure.
    Rothgeb TM; Jones BN; Hayes DF; Gurd RS
    Biochemistry; 1977 Dec; 16(26):5813-8. PubMed ID: 588556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [25-oxindolylalanine]glucagon and [27-methionine sulfoxide]glucagon: preparation, purification, and characterization.
    Coolican SA; Jones BN; England RD; Flanders KC; Condit JD; Gurd RS
    Biochemistry; 1982 Sep; 21(20):4974-81. PubMed ID: 7138842
    [No Abstract]   [Full Text] [Related]  

  • 20. The relation of predicted structure to observed conformation and activity of glucagon analogs containing replacements at positions 19, 22, and 23.
    Murphy J; Zhang WJ; Macaulay W; Fasman G; Merrifield RB
    J Biol Chem; 1987 Dec; 262(36):17304-12. PubMed ID: 3693354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.